Israel's OurCrowd leads $12 million investment to develop COVID-19 vaccine

Israel's OurCrowd leads $12 million investment to develop COVID-19 vaccine
Reuters: Health
Israeli venture investing platform OurCrowd said on Wednesday it would lead a $12 million investment in the newly formed MigVax Corp, which plans to develop a novel COVID-19 vaccine.


No comments:

Post a Comment